Abstract
The accumulation of D-isomers of aspartic acid (D-Asp) in proteins during aging has been implicated in the pathogenesis of Alzheimer's disease, cataracts, and arteriosclerosis. Here, we identified a specific lactacystin-sensitive endopeptidase that cleaves the D-Asp-containing protein and named it D-aspartyl endopeptidase (DAEP). DAEP has a multi-complex structure (MW: 600kDa) and is localized in the inner mitochondrial membrane of mouse and rabbit, but DAEP activity was not detected in Escherichia coli, Saccharomyces cerevisiae, and Caenorhabditis elegans. A specific inhibitor for DAEP was newly synthesized, and inhibited DAEP activity (IC(50), 3microM), a factor of 10 greater than lactacystin on DAEP. On the other hand, the inhibitor did not inhibit either the 20S or 26S proteasome.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aging / metabolism*
-
Animals
-
Aspartic Acid / chemistry
-
Aspartic Acid / metabolism*
-
Aspartic Acid Endopeptidases / antagonists & inhibitors
-
Aspartic Acid Endopeptidases / isolation & purification
-
Aspartic Acid Endopeptidases / metabolism*
-
Caenorhabditis elegans / enzymology
-
Caenorhabditis elegans / genetics
-
Cysteine Endopeptidases / genetics
-
Cysteine Endopeptidases / metabolism
-
Endopeptidases / metabolism
-
Escherichia coli / enzymology
-
Escherichia coli / genetics
-
Female
-
Isomerism
-
Male
-
Mice
-
Mice, Inbred Strains
-
Mitochondria, Liver / enzymology
-
Oligopeptides / chemistry*
-
Oligopeptides / metabolism*
-
Protease Inhibitors / pharmacology
-
Rabbits
-
Saccharomyces cerevisiae / enzymology
-
Saccharomyces cerevisiae / genetics
-
Substrate Specificity
Substances
-
Oligopeptides
-
Protease Inhibitors
-
Aspartic Acid
-
Endopeptidases
-
Cysteine Endopeptidases
-
Aspartic Acid Endopeptidases